Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-01-14

Clinical Trial Update: Janssen Asperger's MRS (Magnetic Resonance Spectroscopy Risperidone Study [Phase 4]

View source ↗

Summary

Phase 4 study evaluating risperidone using magnetic resonance spectroscopy for individuals with Asperger syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RISPERIDONE (RISPERIDONE)

Snippet

Sponsor: Augusta University | Conditions: Asperger's Disorder | Phase 4 | Status: COMPLETED